# PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease

> **NCT02384629** · PHASE4 · WITHDRAWN · sponsor: **Yonsei University**

## Conditions studied

- Coronary Bifurcation Lesions

## Interventions

- **DEVICE:** OCT-guided PCI with AXXESS stent
- **DEVICE:** OCT-guided PCI with conventional DES (Biomatrix flex stent)
- **DEVICE:** Angio-guided PCI with AXXESS stent
- **DEVICE:** Angio-guided PCI with PCI with conventional DES (Biomatrix flex stent)

## Key facts

- **NCT ID:** NCT02384629
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Problem with medical device provider
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02384629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02384629, "PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02384629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*